24 Nov

Results of AGM

Probiot ec Limite d ABN 91 075 170 151 83 Cherry Lane, Laverton North, VIC 3026 Australia Phon e: + 61 3 9278 7555 Fax: + 61 3 9369 6730 Web: www.probiotec.com.au 24 November 2021 Manager Companies Company Announcements Office Australian Stock Exchange Limited Dear Sir Results of Annual General Meeting Probiotec Limited In accordance with Listing Rule 3.13.2 and section 251AA of the Corporations Act, we ad v ise the results of the resolutions , and the proxies received in respect of each resolution are set out in the attached summary. Yours Sincerely Jared Stringer Company Secretary Probiot ec Limite d ABN 91 075 170 151 83 Cherry Lane, Laverton North, VIC 3026 Australia Phon e: + 61 3 9278 7555 Fax: + 61 3 9369 6730 Web: www.probiotec.com.au Probiotec Limited - Annual General Meeting Proxy & Result s Summary 2 4 November 2021 1 Adoption of Remuneration Report The instructions given to validly appoint proxies in respect of the resolution were as follows: In Favour Against Abst ain/Exclusion Proxy’s Discretion 36, 805,108 1,566,200 8,837, 8 22 25,665 The motion was c ar ri ed via poll . 2 R e - election of Director – Mr Jonat han Wenig The instructions given to validly appoint proxies in respect of the resolution were as foll ows: In Fa vou r Against Abst ain/Exc lusio n Prox y’s Discre tion 44,617,082 1,327,915 14,133 1,275,665 The motion was c arri ed via poll . 3 R e - election of Director – Mr Simon Gray The instructions given to validly appoint proxies i n respect of the resolution were as foll ows: In Favour Against Abst ain/Exc lusion Pr oxy’s Discretion 45,941,997 3,000 14,133 1,275,665 The motion was c arri ed via poll . 4 Issue of Performan ce Rights to the Chi ef Executive Officer The instructions given to validly appoint proxies in respect of the resolution were as foll ows: In Favour Against Abst ai n/Ex c lusion Proxy’s Discretion 33, 645,263 4,726,545 8,837,322 25,665 The motion was c arri ed via poll . 5 Provision of Loan to the Chief Executive Officer in relation to 2020 Options The instructions given to validly appoint proxies in respect of the resolut ion were as foll ows: In Favour Against Abst ai n/Exc lusion Proxy’s Discretion 35, 871,270 411,118 10,926, 7 42 25,665 The motion was c arri ed via poll . Probiot ec Limite d ABN 91 075 170 151 83 Cherry Lane, Laverton North, VIC 3026 Australia Phon e: + 61 3 9278 7555 Fax: + 61 3 9369 6730 Web: www.probiotec.com.au About P robiotec Probiotec Limited is a manufacturer, packer and distributor of a range of prescripti on and over - the - counter (OTC) pharmaceuticals, complementary medicines, consumer health products and fast - moving consumer goods. The company owns six manufacturing facilities in Australia and distributes its products both domestically and internationally. Products are manufactured by Probiotec on behalf of a range of clients, including major intern ational companies. Further details about Probiotec ar e available at www.probiotec.com.au Authori sed for release by the board of directors. For further inform a tion contact: Mr W es St ringer, Managing Director (03) 9278 7555
Information on this Website is provided for general information purposes only and is not a substitute for professional advice. ASX Information (including company announcements and prices) is delayed by at least 20 minutes. JSE Information (including company announcements and prices) is delayed by at least 15 minutes. Reliance on the information you access on or from this Website is solely at your own risk. We make no representation or warranty in relation to the future performance of the companies that appear on this Website. Investment in securities involves risk and you should obtain independent professional legal, financial, investment or company advice before acting on any of the information you access on this Website. Using, browsing or otherwise accessing this Website is subject to our Terms and Conditions and our Privacy Policy.

© 2021 Listcorp. ABN 60 166 140 307

Never miss news from Probiotec Limited (ASX:PBP) when you join Listcorp.